Stem Cell Surgery Trials in Heart Failure and Diabetes: A Concise Guide

Preface
Contents
Part I: Heart Failure (United States)
	Chapter 1: Bone Marrow-Derived Mesenchymal Stem Cells in Improving Heart Function in Patients with Heart Failure Caused by Anthracyclines
	Chapter 2: Donor Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients with Cardiomyopathy Caused by Anthracyclines
	Chapter 3: The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial
	Chapter 4: Regression of Fibrosis and Reversal of Diastolic Dysfunction in HFPEF Patients Treated with Allogeneic CDCs
	Chapter 5: Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure
Part II: Heart Failure (Europe)
	Chapter 6: Allogeneic Stem Cell Therapy in Heart Failure
	Chapter 7: Stem Cell Therapy in Advanced Heart Failure
	Chapter 8: Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease
	Chapter 9: Infusion Intracoronary of Mononuclear Autologous Adult Non Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients with Idiopathic Dilated Cardiomyopathy and Heart Failure
	Chapter 10: Cell Therapy in HFpEF
	Chapter 11: Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-Derived Mononuclear Cells on Mortality in Patients with Chronic Post-infarction Heart Failure
	Chapter 12: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients with STEMI
	Chapter 13: Stem Cell Therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study
Part III: Heart Failure (Iran)
	Chapter 14: IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients
	Chapter 15: ICMNC-HF: IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients
Part IV: Heart Failure (China)
	Chapter 16: Treating Heart Failure with hPSC-CMs
Part V: Diabetes Mellitus: Type 1 Diabetes (United States)
	Chapter 17: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
	Chapter 18: A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
	Chapter 19: Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
	Chapter 20: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
Part VI: Diabetes Mellitus: Type 1 Diabetes (China)
	Chapter 21: Stem Cell Educator Therapy in Diabetes
	Chapter 22: Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy
Part VII: Diabetes Mellitus: Type 1 Diabetes (China/Spain)
	Chapter 23: Stem Cell Educator Therapy in Type 1 Diabetes
Part VIII: Diabetes Mellitus: Type 1 Diabetes (South America)
	Chapter 24: Mesenchymal Stem Cells in Patients with Type 1 Diabetes Mellitus
Part IX: Diabetes Mellitus: Type 1 Diabetes (Canada)
	Chapter 25: Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
Part X: Diabetes Mellitus: Type 1 Diabetes (Middle East)
	Chapter 26: Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Patients (MSCTXT1DM)
	Chapter 27: Use of Stem Cells in Diabetes Mellitus Type 1
Part XI: Diabetes Mellitus: Type 1 Diabetes (Sweden)
	Chapter 28: Wharton’s Jelly-Derived Mesenchymal Stromal Cell-Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes
Part XII: Diabetes Mellitus: Type 2 Diabetes (United States)
	Chapter 29: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO)
	Chapter 30: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
Part XIII: Diabetes Mellitus: Type 2 Diabetes (China)
	Chapter 31: Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus
	Chapter 32: Stem Cell Educator Therapy in Diabetes
	Chapter 33: Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy
Part XIV: Diabetes Mellitus: Type 2 Diabetes (Near East)
	Chapter 34: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients
Part XV: Diabetes Mellitus: Type 2 Diabetes (Vietnam)
	Chapter 35: BM-MNC and UC-MSC Infusion for Type 2 Diabetes Mellitus Patients (T2DM)
Part XVI: Other Thoughts
	Chapter 36: Conclusion
		References
Index